AMG 596
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 596, covering 2024-10-29 to 2024-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma [Phase 1]